Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study (TaISENWITCH)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2012 by Lin, Hsi-Hsun, M.D..
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Lin, Hsi-Hsun, M.D.
ClinicalTrials.gov Identifier:
NCT01679964
First received: August 30, 2012
Last updated: September 5, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)